A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: excite (79), inspire (52), motivate (59)

Carboplatin-Pembrolizumab-Pemetrexed

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CARBOPLATIN (AUC 5)-PEMBROLIZUMAB-PEMETREXED Regimen • NSCLC – Carboplatin (AUC5)-Pembrolizumab-Pemetrexed Indication • Pembrolizumab
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Carboplatin-Pembrolizumab-Pemetrexed.pdf

Cisplatin-Pembrolizumab-Pemetrexed

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) CISPLATIN-PEMBROLIZUMAB-PEMETREXED Regimen • NSCLC – Cisplatin-Pembrolizumab-Pemetrexed Indication • Pembrolizumab in combination with
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Cisplatin-Pembrolizumab-Pemetrexed.pdf

Awake craniotomy - patient information

Description
This factsheet contains information about having an awake craniotomy operation.
Url
/Media/UHS-website-2019/Patientinformation/Brain-and-spine/Awake-craniotomy-1194-PIL.pdf

Lazy eye in children - patient information

Description
This factsheet contains information about the two most common treatment options for a lazy eye.
Url
/Media/UHS-website-2019/Patientinformation/Eyes/Childrens-eyes/Lazy-eye-in-children-1783-PIL.pdf

Cytarabine_2000_FludarabineIdarubicin_FLA-Ida

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA CYTARABINE (2000)-FLUDARABINE-IDARUBICIN (FLA-IDA) In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-Cytarabine (2000
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Cytarabine-2000-FludarabineIdarubicin-FLA-Ida.pdf

Cytarabine_1000_FludarabineIdarubicin_FLA-Ida

Description
Chemotherapy Protocol ACUTE MYELOID LEUKAEMIA CYTARABINE (1000)-FLUDARABINE-IDARUBICIN (FLA-IDA) In-Patient Regimen Regimen • Acute Myeloid Leukaemia – InP-Cytarabine (1000
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/AML/Cytarabine-1000-FludarabineIdarubicin-FLA-Ida.pdf

Featured research: COVID-19 vaccine trial

Description
Auto Generated Title Healthy adults aged 18-55 can now contribute to the world's search for an effective COVID-19 vacine
Url
/ClinicalResearchinSouthampton/Public-and-patients/Featured-research-studies/Featured-research-COVID-19-vaccine-trial.aspx

Press release: Leading doctor warns use of blood test to diagnose heart attacks is 'flawed'

Description
A leading cardiac specialist has said some patients who suffer suspected heart attacks could be receiving inappropriate investigations and unnecessary treatment
Url
/AboutTheTrust/Newsandpublications/Latestnews/2019/March/Press-release-Leading-doctor-warns-use-of-blood-test-to-diagnose-heart-attacks-is-flawed.aspx

BEACON protocol v8.0 07Mar2023 signed

Description
A randomised phase IIb trial of BE AC v izumab added to Temozolomide O ± Irin tecan for children with N refractory
Url
/Media/UHS-website-2019/Docs/PaediatricOncology/beacon-protocol-v8.0-07mar2023-signed.pdf

Endometrial-Dostarlimab

Description
Chemotherapy Protocol GYNACOLOGICAL CANCER Dostarlimab Regimen  Endometrial - Dostarlimab Indication  Dostarlimab is indicated for patients with; - proven histological diagnosis of endometrial carcinoma
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Uterine-cancer/Dostarlimab.pdf
41 to 50 of 104
Previous … 3 4 5 6 7 … Next